Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Real-World Performance of 2022 Revised World Health Organization (WHO) Criteria for Mixed Phenotype Acute Leukemia (MPAL) B/Myeloid Defined Only By Isolated MPO Expression (isoMPO)

Alexandra E. Kovach, Sunil S. Raikar, Jemily Malvar, Matthew J. Oberley, Gerald Wertheim, Karen R. Rabin, Jyotinder N. Punia, Alix Seif, Reuven J. Schore, Dragos C. Luca, Terri L. Guinipero, William G. Woods, Viviane Cahen, Yueh-Yun Chi, Maurice R.G. O'Gorman, Brent L. Wood, Etan Orgel

Blood (2023) 142 (Supplement 1): 1467.

https://doi.org/10.1182/blood-2023-174110

Published: 2023

Journal Articles

Impact of Molecular Risk on Efficacy of Blood and Marrow Transplantation for Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Benjamin J Huang, Lauren K. Meyer, Adam Lamble, Jim Wang, Rhonda E Ries, Alan S Gamis, Richard Aplenc, Katherine Tarlock, Todd Cooper, E. Anders Kolb, Todd A. Alonzo, Soheil Meshinchi, Joseph Chewning, William G. Woods, John T. Horan

Blood (2023) 142 (Supplement 1): 655.

https://doi.org/10.1182/blood-2023-186955

Published: 2023

Journal Articles

Chronic conditions, late mortality, and health status after childhood AML: a Childhood Cancer Survivor Study report

Lucie M. Turcotte, Jillian A. Whitton, Wendy M. Leisenring, Rebecca M. Howell, Joseph P. Neglia, Rachel Phelan, Kevin C. Oeffinger, Kirsten K. Ness, William G. Woods, E. Anders Kolb, Leslie L. Robison, Gregory T. Armstrong, Eric J. Chow

Blood (2023) 141 (1): 90–101.

https://doi.org/10.1182/blood.2022016487

Published: 2023

Includes: Supplemental data

Journal Articles

Significant Improvements in Survival for Patients with t(6;9)(p23;q34)/ DEK-NUP214 in Contemporary Trials with Intensification of Therapy: A Report from the Children's Oncology Group

Katherine Tarlock, Todd A. Alonzo, Robert B. Gerbing, Yi-Cheng Wang, Rhonda E. Ries, Betsy A Hirsch, Beverly Lange, William G. Woods, Todd M. Cooper, Alan S. Gamis, Jessica A. Pollard, Richard Aplenc, Anders E. Kolb, Soheil Meshinchi

Blood (2021) 138 (Supplement 1): 519.

https://doi.org/10.1182/blood-2021-147576

Published: 2021

Journal Articles

Standardization in the Diagnosis of Mixed Phenotype Acute Leukemia (MPAL): Semiquantitative, Universally Applicable Flow Cytometric Criteria for Immunophenotypic Lineage Assignment and Isolated MPO

Alexandra E. Kovach, Sunil S. Raikar, Matthew J. Oberley, Gerald Wertheim, Karen R Rabin, Jyotinder N. Punia, Alix E. Seif, Reuven J Schore, Dragos C. Luca, Terri Guinipero, William G Woods, Viviane Cahen, Maurice R.G. O'Gorman, Etan Orgel, Brent L. Wood

Blood (2021) 138 (Supplement 1): 4475.

https://doi.org/10.1182/blood-2021-154295

Published: 2021

Journal Articles

CEBPA -bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children’s Oncology Group

Katherine Tarlock, Adam J. Lamble, Yi-Cheng Wang, Robert B. Gerbing, Rhonda E. Ries, Michael R. Loken, Lisa Eidenschink Brodersen, Laura Pardo, Amanda Leonti, Jenny L. Smith, Tiffany A. Hylkema, William G. Woods, Todd M. Cooper, E. Anders Kolb, Alan S. Gamis, Richard Aplenc, Todd A. Alonzo, Soheil Meshinchi

Blood (2021) 138 (13): 1137–1147.

https://doi.org/10.1182/blood.2020009652

Published: 2021

Includes: Supplemental data

Journal Articles

Somatic Bzip Mutations of CEBPA Are Associated with Favorable Outcome Regardless of Presence As Single Vs. Double Mutation

Katherine Tarlock, MD, Todd A. Alonzo, PhD, Yi-Cheng Wang, Robert B. Gerbing, Rhonda E. Ries, MA, Tiffany A. Hylkema, BS, William G. Woods, MD, Todd M Cooper, DO, Alan S Gamis, MD MPH, Richard Aplenc, MD PhD, Soheil Meshinchi, MD PhD

Blood (2019) 134 (Supplement_1): 181.

https://doi.org/10.1182/blood-2019-126273

Published: 2019

Journal Articles

Chronic Health Conditions and Late Mortality Among Survivors of Childhood Acute Myeloid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS)

Lucie M Turcotte, MD, John A Whitton, MS, Wendy M. Leisenring, ScD, Todd Gibson, PhD, Rebecca M Howell, PhD, Kevin R. Krull, PhD, Joseph P. Neglia, MD MPH, Kevin C Oeffinger, MD, Kirsten K. Ness, PhD, William G. Woods, MD, E. Anders Kolb, MD, Leslie L. Robison, PhD, Gregory T Armstrong, MD, Eric J Chow, MD MPH

Blood (2019) 134 (Supplement_1): 1315.

https://doi.org/10.1182/blood-2019-123477

Published: 2019

Journal Articles

Clinical Outcomes in Pediatric Mixed Phenotype Acute Leukemia (MPAL) Differ Depending on Disease Classification Criteria; A Multi-Center Cohort Study

Matthew J. Oberley, MD PhD, Gerald Wertheim, MD, PhD, Sunil S. Raikar, MD, Jemily Malvar, Richard Sposto, PhD, Jyotinder N. Punia, MD, Karen R. Rabin, MD PhD, Alix E. Seif, MD, Reuven J. Schore, MD, Dragos C. Luca, MD, Terri Guinipero, MD, William G. Woods, MD, Maurice R.G. O'Gorman, MD PhD, Etan Orgel, MD MS

Blood (2018) 132 (Supplement 1): 4080.

https://doi.org/10.1182/blood-2018-99-117377

Published: 2018

Journal Articles

Minimal Residual Disease Risk-Stratification in Pediatric Mixed Phenotype Acute Leukemia: Results of a Multi-Center Cohort Study

Matthew J. Oberley, MD PhD, Sunil S. Raikar, MD, Jemily Malvar, Gerald Wertheim, MD, PhD, Alix E. Seif, MD, Terri Guinipero, MD, Richard Sposto, PhD, Karen R. Rabin, MD PhD, Jyotinder N. Punia, MD, Reuven J. Schore, MD, Dragos C. Luca, MD, William G. Woods, MD, Maurice R.G. O'Gorman, MD PhD, Etan Orgel, MD MS

Blood (2018) 132 (Supplement 1): 558.

https://doi.org/10.1182/blood-2018-99-113606

Published: 2018

Journal Articles

Isolated myeloperoxidase expression in pediatric B/myeloid mixed phenotype acute leukemia is linked with better survival

Sunil S. Raikar, Sunita I. Park, Traci Leong, David L. Jaye, Frank G. Keller, John T. Horan, William G. Woods

Blood (2018) 131 (5): 573–577.

https://doi.org/10.1182/blood-2017-09-807602

Published: 2018

Includes: Supplemental data

Journal Articles

Outcomes Based on CNS Disease Status in Pediatric Acute Myeloid Leukemia and the Role of Peripheral Blood Contamination in Diagnostic Lumbar Punctures; A Report from the Children's Oncology Group Studies AAML0531 and AAML1031

Matthew A. Kutny, MD, Todd A Alonzo, PhD, Robert B Gerbing, Yi-Cheng Wang, Richard Aplenc, MD, Alan S Gamis, MD MPH, James Feusner, William G. Woods, MD, Soheil Meshinchi, MD PhD, Donna Johnston, MDFRCPC

Blood (2017) 130 (Supplement 1): 3859.

https://doi.org/10.1182/blood.V130.Suppl_1.3859.3859

Published: 2017

Journal Articles

Occurrence of Cardiotoxicity and the Impact on Outcomes Among Children Treated on the AAML0531 Clinical Trial: A Report from the Children's Oncology Group

Kelly D Getz, Lillian Sung, MD PhD, Bonnie Ky, MD, Robert B Gerbing, Kasey J Leger, Allison Barz, Leah Sack, William G Woods, MD, Todd A Alonzo, PhD, Alan S Gamis, MD MPH, Richard Aplenc, MD

Blood (2017) 130 (Supplement 1): 3875.

https://doi.org/10.1182/blood.V130.Suppl_1.3875.3875

Published: 2017

Journal Articles

Efficacy of ALL Therapy for WHO2016-Defined Mixed Phenotype Acute Leukemia: A Report from the Children's Oncology Group

Etan Orgel, MD MS, Thomas B. Alexander, MDMPH, Brent Wood, MDPhD, Samir Kahwash, MD, Meenakshi Devidas, Yunfeng Dai, PhD, Todd A Alonzo, PhD, Charles G. Mullighan, MBBS, MD, Hiroto Inaba, MD, Stephen P. Hunger, MD, Alan S Gamis, MD MPH, Andrew J. Carroll, III, PhD, Nyla A. Heerema, PhD, Jason Berman, MD, William G Woods, MD, Mignon L. Loh, MD, Patrick A. Zweidler-McKay, MDPhD, John T Horan, MD

Blood (2017) 130 (Supplement 1): 883.

https://doi.org/10.1182/blood.V130.Suppl_1.883.883

Published: 2017

Journal Articles

Incidence and Predictors of Adverse Respiratory Events during Induction Therapy in Children with Acute Myeloid Leukemia

Lane Miller, MD, Sharon M. Castellino, MD MSc, Ann Mertens, PhD, Frank G Keller, MD, William G Woods, MD

Blood (2017) 130 (Supplement 1): 2590.

https://doi.org/10.1182/blood.V130.Suppl_1.2590.2590

Published: 2017

Journal Articles

Isolated Myeloperoxidase Expression in Pediatric B/Myeloid Mixed Phenotype Acute Leukemia Is Associated with Improved Survival Using ALL-Only Regimens

Sunil S Raikar, MD, Sunita Park, MD, Traci Leong, PhD, David L Jaye, MD, Frank G Keller, MD, John T Horan, MD, William G Woods, MD

Blood (2017) 130 (Supplement 1): 1290.

https://doi.org/10.1182/blood.V130.Suppl_1.1290.1290

Published: 2017

Journal Articles

The Effect of Traumatic Diagnostic Lumbar Puncture in De Novo Pediatric Acute Myeloid Leukemia - a Report from the Children's Oncology Group

Donna L Johnston, MD FRCPC, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Richard Aplenc, MD PhD, William G Woods, MD, Soheil Meshinchi, MD PhD, Alan S. Gamis, MD MPH

Blood (2016) 128 (22): 4016.

https://doi.org/10.1182/blood.V128.22.4016.4016

Published: 2016

Journal Articles

Outcome of Pediatric Patients with Acute Myeloid Leukemia and -5/5q-Abnormalities Enrolled On Five Children's Oncology Group Acute Myeloid Leukemia Treatment Protocols

Donna L Johnston, MD, FRCPC, Todd A. Alonzo, PhD, Robert B. Gerbing, M.A., Betsy A. Hirsch, PhD, Nyla A. Heerema, PhD, Yaddanapudi Ravindranath, MBBS, William G. Woods, MD, Beverly J. Lange, MD, Alan S. Gamis, MD, MPH, Susana C. Raimondi, PhD

Blood (2012) 120 (21): 1414.

https://doi.org/10.1182/blood.V120.21.1414.1414

Published: 2012

Journal Articles

Acute Myeloid Leukemia with t(6;9)(p23;q34) Is Associated Poor Outcome in Childhood AML Regardless of FLT3/ITD Status, A Report From Children's Oncology Group.

Pilar Palomo Moraleda, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Yaddanapudi Ravindranath, MD, Beverly Lange, MD, William G. Woods, MD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2012) 120 (21): 2541.

https://doi.org/10.1182/blood.V120.21.2541.2541

Published: 2012

Journal Articles

Hematopoietic Cell Transplant Versus Chemotherapy As Consolidation Treatment for Pediatric AML with Poor-Risk Cytogenetics

Michael J. Kelly, MD, MPH, John T. Horan, M.D., M.P.H., Todd A. Alonzo, PhD, Mary Eapen, MBBS, Robert B. Gerbing, M.A., Wensheng He, PhD, Beverly J. Lange, MD, Susan K. Parsons, MD, MRP, William G. Woods, MD

Blood (2012) 120 (21): 127.

https://doi.org/10.1182/blood.V120.21.127.127

Published: 2012

NARROW

Real-World Performance of 2022 Revised World Health Organization (WHO) Criteria for Mixed Phenotype Acute Leukemia (MPAL) B/Myeloid Defined Only By Isolated MPO Expression (isoMPO)

Impact of Molecular Risk on Efficacy of Blood and Marrow Transplantation for Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Chronic conditions, late mortality, and health status after childhood AML: a Childhood Cancer Survivor Study report

Significant Improvements in Survival for Patients with t(6;9)(p23;q34)/ DEK-NUP214 in Contemporary Trials with Intensification of Therapy: A Report from the Children's Oncology Group

Standardization in the Diagnosis of Mixed Phenotype Acute Leukemia (MPAL): Semiquantitative, Universally Applicable Flow Cytometric Criteria for Immunophenotypic Lineage Assignment and Isolated MPO

CEBPA -bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children’s Oncology Group

Somatic Bzip Mutations of CEBPA Are Associated with Favorable Outcome Regardless of Presence As Single Vs. Double Mutation

Chronic Health Conditions and Late Mortality Among Survivors of Childhood Acute Myeloid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS)

Clinical Outcomes in Pediatric Mixed Phenotype Acute Leukemia (MPAL) Differ Depending on Disease Classification Criteria; A Multi-Center Cohort Study

Minimal Residual Disease Risk-Stratification in Pediatric Mixed Phenotype Acute Leukemia: Results of a Multi-Center Cohort Study

Isolated myeloperoxidase expression in pediatric B/myeloid mixed phenotype acute leukemia is linked with better survival

Outcomes Based on CNS Disease Status in Pediatric Acute Myeloid Leukemia and the Role of Peripheral Blood Contamination in Diagnostic Lumbar Punctures; A Report from the Children's Oncology Group Studies AAML0531 and AAML1031

Occurrence of Cardiotoxicity and the Impact on Outcomes Among Children Treated on the AAML0531 Clinical Trial: A Report from the Children's Oncology Group

Efficacy of ALL Therapy for WHO2016-Defined Mixed Phenotype Acute Leukemia: A Report from the Children's Oncology Group

Incidence and Predictors of Adverse Respiratory Events during Induction Therapy in Children with Acute Myeloid Leukemia

Isolated Myeloperoxidase Expression in Pediatric B/Myeloid Mixed Phenotype Acute Leukemia Is Associated with Improved Survival Using ALL-Only Regimens

The Effect of Traumatic Diagnostic Lumbar Puncture in De Novo Pediatric Acute Myeloid Leukemia - a Report from the Children's Oncology Group

Outcome of Pediatric Patients with Acute Myeloid Leukemia and -5/5q-Abnormalities Enrolled On Five Children's Oncology Group Acute Myeloid Leukemia Treatment Protocols

Acute Myeloid Leukemia with t(6;9)(p23;q34) Is Associated Poor Outcome in Childhood AML Regardless of FLT3/ITD Status, A Report From Children's Oncology Group.

Hematopoietic Cell Transplant Versus Chemotherapy As Consolidation Treatment for Pediatric AML with Poor-Risk Cytogenetics

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only